Pharmafile Logo

Fleet Laboratories

Fleet Laboratories Ltd are part of the DDD Group of Companies which was established in 1912 and is still privately owned. We work with customers in the health and beauty industry manufacturing pharmaceutical products on behalf of the licence holder and developing and manufacturing toiletry products for both brand owners and retailers. We have a diverse range of customers, some of whom we have worked with for nearly 30 years. Depending on your business need, we have a flexible range of services available.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

94 Rickmansworth Road, Watford, Herts, WD18 7JJ, United Kingdom
+44 (0)1923 229251

 Latest Content from PMHub 

The Periodic Table of Pharma Multi-channel Marketing

Our Periodic Table of Pharma Multi-channel Marketing has been designed to provide pharma marketing folk with an at-a-glance overview of all the key elements needed for multi-channel marketing activity.

Could hackers threaten your health?

Increasing cyber threats mean medical device providers must now take security matters more seriously, writes our Say technology blogger.

Hunt vs Hawking: We’ll call it a draw

Who won the recent bout between Jeremy Hunt and Stephen Hawking? We'll let you score the cards.

The changing face of medical communications over the past 15 years

As Porterhouse Medical celebrates its 15 year anniversary, joint MD and founder, Brian Parsons reflects on the changes to the medical communications industry over the past decade and a half.

Indians scalp cowboys in patent war

An unlikely treaty between global pharma and native Americans

Wilmington Healthcare appoints new Account Director

Press Releases | September 26, 2017 | Wilmington Healthcare

Healthcare intelligence provider Wilmington Healthcare, which incorporates Binley’s, NHiS, Wellards and HSJ, has strengthened its salesforce with the appointment of Gareth Thurston as Account Director.

Perspective on biotech

In this supplementary issue of Perspective, we reveal the emerging technologies taking the biotech world by storm and ask if the definition of a biotech organisation needs updating.

Lucid CEO discusses communication excellence in a multimedia world

“The two words 'information' and 'communication' are often used interchangeably, but they signify quite different things. Information is giving out; communication is getting through,” Sydney J. Harris, a renowned Anglo-American...

What will the NHS’s Capped Expenditure Process (CEP) mean for pharma?

Paul Midgley, Director of NHS Insight at Wilmington Healthcare, explains how pharma should tailor its approach

Why AI might be the rep’s best friend

When looking for the next big thing in digital communication, there’s nothing bigger than the sweeping changes promised by artificial intelligence. There’s little doubt that AI is coming to pharma...